Item 7.01 Regulation FD Disclosure.

On August 20, 2020, Windtree Therapeutics, Inc. (the "Company") released an investor presentation to be used in presentations to investors from time to time. A copy of this investor presentation is attached hereto as Exhibit 99.1.

The information in this Item 7.01 (including Exhibit 99.1) is being furnished solely to satisfy the requirements of Regulation FD and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

The following exhibits are being filed herewith:





Exhibit
No.                                         Document

99.1        Windtree Therapeutics, Inc. Investor Presentation dated August 20, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses